Human macrophage immunometabolism regulator (MACIR) in patients with periodontitis

Karol Serwin1, Małgorzata Kozak2, Małgorzata Mazurek-Mochol3

  • 1Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arkońska 4, 71-455 Szczecin, Poland.

Immunobiology
|November 17, 2023
PubMed
Abstract

Insights

Human macrophage immunometabolism regulator (MACIR) expression is lower in periodontitis patients. Inflammatory cytokines IL-1β and TNF-α decrease MACIR gene and protein levels in gingival fibroblasts, suggesting MACIR

Area of Science:

  • Immunology
  • Oral Biology
  • Molecular Biology

Background:

  • Periodontitis is an inflammatory disease driven by bacterial infection.
  • Macrophages are key immune cells involved in periodontitis.
  • Human macrophage immunometabolism regulator (MACIR) influences macrophage function and immune response.

Purpose of the Study:

  • To investigate MACIR gene and protein expression in gingival tissues of periodontitis patients.
  • To examine the effect of IL-1β and TNF-α on MACIR expression in human gingival fibroblasts.

Main Methods:

  • Real-time PCR for MACIR mRNA quantification.
  • Immunofluorescent staining and Western blotting for MACIR protein analysis.
  • Stimulation of human gingival fibroblasts with IL-1β and TNF-α.

Main Results:

  • MACIR mRNA levels were significantly lower in periodontitis tissues compared to healthy controls.
  • IL-1β and TNF-α significantly decreased MACIR mRNA expression in gingival fibroblasts.
  • Both cytokines reduced MACIR protein expression in cultured human gingival fibroblasts.

Conclusions:

  • MACIR plays a significant role in regulating the inflammatory process in periodontitis.
  • Reduced MACIR expression may enhance macrophage activation, leading to increased inflammation and tissue destruction.
  • MACIR is a potential therapeutic target for periodontitis management.

Related Concept Videos